Pharmaceutical companies are continuously exploring new patient-centric opportunities to improve efficiency in clinical development, better engage with clinical trial participants, and reduce development costs and timelines.
This 2-day course will provide insights to Sponsors, CROs, service providers and Investigational Sites who would like to explore new ways to improve clinical trial conduct and related services by implementing patient-centric remote trials.
The covid-19 pandemic has only accelerated the need for alternatives to the classical approaches to clinical research and we gained a lot of experience from this crisis situation. That experience will also be shared in the course.
The course provides a mixture of presentations, discussions and practical exercises aimed at providing you with a practical understanding of the new technology and digital channels and how they can facilitate patient-centric remote trials.
The trainers are representing all stakeholders: sponsor, service & technology providers, investigator, patient, and regulatory agency. They will share their experience in a very practical way.
Virtual or remote trials offer tremendous benefits to sponsors, patients, investigators, nurses and service providers. We will be taking a deep dive into patient-centric remote trial conduct and explore how virtual trials and modern technology offer new opportunities for all involved and interested in patient-centric strategies.
Traditional clinical trial burdens, such as inconvenient site locations, logistical concerns, time and financial constraints, and missed visits may result in patient dropouts and increase non-compliance. Creating a more patient-centric virtual or remote trial setting and utilizing smart devices and new technology can help reduce these burdens and enable patients to take part in clinical trials remotely and giving them access to treatment they may not have otherwise.
In addition to providing you with the basics of patient-centric remote trials, this course will also provide insight on the regulatory landscape regarding, e.g. Home Nursing, Direct-to-patient IMP shipment and e-informed consent.
Trainers will encourage for team discussion around recent experiences with the covid-19 outbreak and the consequences on clinical research execution.